메뉴 건너뛰기




Volumn 3, Issue 5, 2012, Pages 535-545

A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma

Author keywords

Chemotherapeutic drug; Neuroblastoma; Oncogene; Transcription

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; ELLIPTICINE; MYC PROTEIN; PINAFIDE; TOPOTECAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR B MYB; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; DNA TOPOISOMERASE INHIBITOR; DRUG DERIVATIVE; MYBL2 PROTEIN, HUMAN; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; TRANSACTIVATOR PROTEIN;

EID: 84867319101     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.498     Document Type: Article
Times cited : (16)

References (45)
  • 1
    • 0041475779 scopus 로고    scopus 로고
    • Neuroblastoma: biology and molecular and chromosomal pathology
    • Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 2003; 4:472-480.
    • (2003) Lancet Oncol , vol.4 , pp. 472-480
    • Schwab, M.1    Westermann, F.2    Hero, B.3    Berthold, F.4
  • 3
    • 0023260866 scopus 로고
    • Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients
    • Brodeur GM, Hayes FA, Green AA, Casper JT, Wasson J, Wallach S, Seeger RC. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res. 1987; 47:4248-4253.
    • (1987) Cancer Res , vol.47 , pp. 4248-4253
    • Brodeur, G.M.1    Hayes, F.A.2    Green, A.A.3    Casper, J.T.4    Wasson, J.5    Wallach, S.6    Seeger, R.C.7
  • 4
    • 0022575467 scopus 로고
    • Gene amplification in human neuroblastomas: basic mechanisms and clinical implications
    • Brodeur GM, Seeger RC. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications. Cancer Genet Cytogenet. 1986; 19:101-111.
    • (1986) Cancer Genet Cytogenet , vol.19 , pp. 101-111
    • Brodeur, G.M.1    Seeger, R.C.2
  • 5
    • 0021261878 scopus 로고
    • Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
    • Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984; 224:1121-1124.
    • (1984) Science , vol.224 , pp. 1121-1124
    • Brodeur, G.M.1    Seeger, R.C.2    Schwab, M.3    Varmus, H.E.4    Bishop, J.M.5
  • 11
    • 56749184298 scopus 로고    scopus 로고
    • Reflecting on 25 years with MYC
    • Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008; 8:976-990.
    • (2008) Nat Rev Cancer , vol.8 , pp. 976-990
    • Meyer, N.1    Penn, L.Z.2
  • 13
    • 0024441031 scopus 로고
    • Molecular biology and genetics of human neuroblastoma
    • Brodeur GM, Fong CT. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 1989; 41:153-174.
    • (1989) Cancer Genet Cytogenet , vol.41 , pp. 153-174
    • Brodeur, G.M.1    Fong, C.T.2
  • 14
    • 0028305310 scopus 로고
    • MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells
    • Corvi R, Amler LC, Savelyeva L, Gehring M, Schwab M. MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Proc Natl Acad Sci U S A. 1994; 91:5523-5527.
    • (1994) Proc Natl Acad Sci U S A , vol.91 , pp. 5523-5527
    • Corvi, R.1    Amler, L.C.2    Savelyeva, L.3    Gehring, M.4    Schwab, M.5
  • 16
    • 0026844368 scopus 로고
    • Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells
    • Graf T. Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells. Curr Opin Genet Dev. 1992; 2:249-255.
    • (1992) Curr Opin Genet Dev , vol.2 , pp. 249-255
    • Graf, T.1
  • 18
    • 0000257239 scopus 로고
    • Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene
    • Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H, Gonda TJ, Ishii S. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci U S A. 1989; 86:5758-5762.
    • (1989) Proc Natl Acad Sci U S A , vol.86 , pp. 5758-5762
    • Sakura, H.1    Kanei-Ishii, C.2    Nagase, T.3    Nakagoshi, H.4    Gonda, T.J.5    Ishii, S.6
  • 19
    • 0027190042 scopus 로고
    • Functional domains of the human B-myb gene product
    • Nakagoshi H, Takemoto Y, Ishii S. Functional domains of the human B-myb gene product. J Biol Chem. 1993; 268:14161-14167.
    • (1993) J Biol Chem , vol.268 , pp. 14161-14167
    • Nakagoshi, H.1    Takemoto, Y.2    Ishii, S.3
  • 20
    • 0026083897 scopus 로고
    • Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells
    • Golay J, Capucci A, Arsura M, Castellano M, Rizzo V, Introna M. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood. 1991; 77:149-158.
    • (1991) Blood , vol.77 , pp. 149-158
    • Golay, J.1    Capucci, A.2    Arsura, M.3    Castellano, M.4    Rizzo, V.5    Introna, M.6
  • 21
    • 0025941870 scopus 로고
    • Growth regulated expression of B-myb in fibroblasts and hematopoietic cells
    • Reiss K, Travali S, Calabretta B, Baserga R. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. J Cell Physiol. 1991; 148:338-343.
    • (1991) J Cell Physiol , vol.148 , pp. 338-343
    • Reiss, K.1    Travali, S.2    Calabretta, B.3    Baserga, R.4
  • 22
    • 0026783836 scopus 로고
    • Characterization and cell cycle-regulated expression of mouse B-myb
    • Lam EW, Robinson C, Watson RJ. Characterization and cell cycle-regulated expression of mouse B-myb. Oncogene. 1992; 7:1885-1890.
    • (1992) Oncogene , vol.7 , pp. 1885-1890
    • Lam, E.W.1    Robinson, C.2    Watson, R.J.3
  • 24
    • 0033214067 scopus 로고    scopus 로고
    • B-myb is required for inner cell mass formation at an early stage of development
    • Tanaka Y, Patestos NP, Maekawa T, Ishii S. B-myb is required for inner cell mass formation at an early stage of development. J Biol Chem. 1999; 274:28067-28070.
    • (1999) J Biol Chem , vol.274 , pp. 28067-28070
    • Tanaka, Y.1    Patestos, N.P.2    Maekawa, T.3    Ishii, S.4
  • 25
    • 0026632658 scopus 로고
    • B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines
    • Arsura M, Introna M, Passerini F, Mantovani A, Golay J. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood. 1992; 79:2708-2716.
    • (1992) Blood , vol.79 , pp. 2708-2716
    • Arsura, M.1    Introna, M.2    Passerini, F.3    Mantovani, A.4    Golay, J.5
  • 26
    • 0026469084 scopus 로고
    • Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression
    • Sala A, Calabretta B. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc Natl Acad Sci U S A. 1992; 89:10415-10419.
    • (1992) Proc Natl Acad Sci U S A , vol.89 , pp. 10415-10419
    • Sala, A.1    Calabretta, B.2
  • 27
    • 0030070757 scopus 로고    scopus 로고
    • B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells
    • Bies J, Hoffman B, Amanullah A, Giese T, Wolff L. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene. 1996; 12:355-363.
    • (1996) Oncogene , vol.12 , pp. 355-363
    • Bies, J.1    Hoffman, B.2    Amanullah, A.3    Giese, T.4    Wolff, L.5
  • 29
    • 0027104314 scopus 로고
    • Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship
    • Fosse P, Rene B, Charra M, Paoletti C, Saucier JM. Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship. Mol Pharmacol. 1992; 42:590-595.
    • (1992) Mol Pharmacol , vol.42 , pp. 590-595
    • Fosse, P.1    Rene, B.2    Charra, M.3    Paoletti, C.4    Saucier, J.M.5
  • 31
    • 0029015354 scopus 로고
    • Topoisomerase II binds to ellipticine in the absence or presence of DNA Characterization of enzyme-drug interactions by fluorescence spectroscopy
    • Froelich-Ammon SJ, Patchan MW, Osheroff N, Thompson RB. Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy. J Biol Chem. 1995; 270:14998-15004.
    • (1995) J Biol Chem , vol.270 , pp. 14998-15004
    • Froelich-Ammon, S.J.1    Patchan, M.W.2    Osheroff, N.3    Thompson, R.B.4
  • 32
    • 0032189683 scopus 로고    scopus 로고
    • Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
    • Pommier Y, Pourquier P, Fan Y, Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta. 1998; 1400:83-105.
    • (1998) Biochim Biophys Acta , vol.1400 , pp. 83-105
    • Pommier, Y.1    Pourquier, P.2    Fan, Y.3    Strumberg, D.4
  • 33
    • 0035029153 scopus 로고    scopus 로고
    • Tumor cell death induced by topoisomerasetargeting drugs
    • Li TK, Liu LF. Tumor cell death induced by topoisomerasetargeting drugs. Annu Rev Pharmacol Toxicol. 2001; 41:53-77.
    • (2001) Annu Rev Pharmacol Toxicol , vol.41 , pp. 53-77
    • Li, T.K.1    Liu, L.F.2
  • 35
    • 22744438407 scopus 로고    scopus 로고
    • Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis
    • Ioanoviciu A, Antony S, Pommier Y, Staker BL, Stewart L, Cushman M. Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis. J Med Chem. 2005; 48:4803-4814.
    • (2005) J Med Chem , vol.48 , pp. 4803-4814
    • Ioanoviciu, A.1    Antony, S.2    Pommier, Y.3    Staker, B.L.4    Stewart, L.5    Cushman, M.6
  • 36
    • 0030826233 scopus 로고    scopus 로고
    • A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons
    • Capranico G, Binaschi M, Borgnetto ME, Zunino F, Palumbo M. A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons. Trends Pharmacol Sci. 1997; 18:323-329.
    • (1997) Trends Pharmacol Sci , vol.18 , pp. 323-329
    • Capranico, G.1    Binaschi, M.2    Borgnetto, M.E.3    Zunino, F.4    Palumbo, M.5
  • 37
    • 0031759531 scopus 로고    scopus 로고
    • Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study
    • Nitschke R, Parkhurst J, Sullivan J, Harris MB, Bernstein M, Pratt C. Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study. J Pediatr Hematol Oncol. 1998; 20:315-318.
    • (1998) J Pediatr Hematol Oncol , vol.20 , pp. 315-318
    • Nitschke, R.1    Parkhurst, J.2    Sullivan, J.3    Harris, M.B.4    Bernstein, M.5    Pratt, C.6
  • 40
    • 65949108394 scopus 로고    scopus 로고
    • B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells
    • Mannefeld M, Klassen E, Gaubatz S. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells. Cancer Res. 2009; 69:4073-4080.
    • (2009) Cancer Res , vol.69 , pp. 4073-4080
    • Mannefeld, M.1    Klassen, E.2    Gaubatz, S.3
  • 43
    • 0042912912 scopus 로고    scopus 로고
    • Clinical and cellular pharmacology in relation to solid tumours of childhood
    • Estlin EJ, Veal GJ. Clinical and cellular pharmacology in relation to solid tumours of childhood. Cancer Treat Rev. 2003; 29:253-273.
    • (2003) Cancer Treat Rev , vol.29 , pp. 253-273
    • Estlin, E.J.1    Veal, G.J.2
  • 44
    • 79960930191 scopus 로고    scopus 로고
    • Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors
    • Mairs RJ, Boyd M. Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors. Semin Nucl Med. 2011; 41:334-344.
    • (2011) Semin Nucl Med , vol.41 , pp. 334-344
    • Mairs, R.J.1    Boyd, M.2
  • 45
    • 34247541700 scopus 로고    scopus 로고
    • Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells
    • Tavner F, Frampton J, Watson RJ. Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells. Oncogene. 2007; 26:2727-2735.
    • (2007) Oncogene , vol.26 , pp. 2727-2735
    • Tavner, F.1    Frampton, J.2    Watson, R.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.